HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2014 | $48.7 M |
2015 | $43.5 M |
Total: | $92.2 M |
Period | Weight, tons. |
---|---|
2014 | 20.7 |
2015 | 28.6 |
Total: | 49.4 |
Group product | 2014 | 2015 | Ch. | ∑ (2014-2015) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $42.3 M | $38.8 M | 8% | $81.1 M | 88% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $6.4 M | $4.7 M | 26% | $11.1 M | 12% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | $385 | --- | 100% | $385 | 0% |
Total: | $48.7 M | $43.5 M | $92.2 M |
№ | Country | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Germany | $4.43 B | 20.6% |
2 | France | $1.94 B | 9% |
3 | United States | $1.25 B | 5.8% |
4 | Italy | $1.24 B | 5.8% |
5 | India | $1.14 B | 5.3% |
6 | Switzerland | $1.05 B | 4.9% |
7 | Hungary | $929 M | 4.3% |
8 | United Kingdom | $924 M | 4.3% |
9 | Netherlands | $906 M | 4.2% |
10 | Slovenia | $812 M | 3.8% |
11 | Spain | $574 M | 2.7% |
12 | Austria | $569 M | 2.6% |
13 | Belgium | $529 M | 2.5% |
14 | Ireland | $479 M | 2.2% |
15 | Denmark | $391 M | 1.8% |
... | ... | ... | ... |
31 | Latvia | $111 M | 0.5% |
32 | Serbia | $101 M | 0.5% |
33 | Singapore | $92.2 M | 0.4% |
34 | Turkey | $88 M | 0.4% |
35 | Portugal | $87.8 M | 0.4% |
... | ... | ... | ... |
The total for all countries: | $21.5 B | 100% |
№ | Region | ∑ (2014-2015) | Ratio |
---|---|---|---|
1 | Moskva | $89.6 M | 97.1% |
2 | Nijegorodskaya oblast | $2.6 M | 2.9% |
3 | Sahalinskaya oblast | $243 | 0% |
4 | Primorskiy kray | $142 | 0% |
By all regions: | $92.2 M | 100% |